Authors: BERIS P SAMII K DARBELLAY R ZOUMBOS N TSOPLOU P PREUDHOMME C FENAUX P

Citation: P. Beris et al., IRON OVERLOAD IN PATIENTS WITH SIDEROBLASTIC ANEMIA IS NOT RELATED TOTHE PRESENCE OF THE HEMOCHROMATOSIS CYS282TYR AND HIS63ASP MUTATIONS, Blood, 90(10), 1997, pp. 886-886

Authors: TSOPLOU P KOURAKLISYMEONIDIS A THANOPOULOU E ORPHANOS V ZOUMBOS N

Citation: P. Tsoplou et al., APOPTOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) - DIFFERENTIAL INVOLVEMENT OF MARROW-CELLS IN EARLY VERSUS ADVANCED EASES AND CORRELATION WITH THE EXPRESSION OF APOPTOSIS-RELATED GENES, Blood, 90(10), 1997, pp. 895-895

Authors: TSOPLOU P KOURAKLI A ORPHANOS V THANOPOULOU E ZOUMBOS P

Citation: P. Tsoplou et al., PROGRAMMED CELL-DEATH (APOPTOSIS) IN THE MARROW OF PATIENTS WITH MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISEASES IS NOT ASSOCIATED WITH EXPRESSION OF C-MYC AND P53, Experimental hematology, 24(9), 1996, pp. 308-308

Authors: TSOPLOU P KOURAKLI A ZOUMBOS N

Citation: P. Tsoplou et al., ADVANCED-STAGE APOPTOSIS IS NOT DETECTED IN FRESH MARROW-CELLS FROM PATIENTS WITH MEGALOBLASTIC-ANEMIA DUE TO B12 DEFICIENCY, Blood, 88(10), 1996, pp. 2783-2783

Authors: TSOPLOU P ZOUMBOS N

Citation: P. Tsoplou et N. Zoumbos, PROGRAMMED CELL-DEATH (PCD) IN THE MARROW OF PATIENTS WITH MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISEASES CONCERNS ALMOST EXCLUSIVELY CD34+ CELLS, Blood, 88(10), 1996, pp. 370-370

Authors: TSOPLOU P KOURAKLI R ZOUMBOS N

Citation: P. Tsoplou et al., PROGRAMMED CELL-DEATH (APOPTOSIS) IN THE MARROW OF PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISEASES, Blood, 84(10), 1994, pp. 10000637-10000637